PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)
Clinical trials for PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) explained in plain language.
Never miss a new study
Get alerted when new PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY) trials appear
Sign up with your email to follow new studies for PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
Genom att skicka in godkänner du våra Användarvillkor
-
New balloon treatment for leg artery disease shows promise in Real-World study
Disease control ENROLLING_BY_INVITATIONThis study is following 300 people with blocked leg arteries who received a special balloon coated with a drug (paclitaxel) to open the vessel. The goal is to see if the balloon keeps the artery open for at least a year without major problems like amputation or needing another pr…
Matched conditions: PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:38 UTC
-
New balloon treatment aims to keep leg arteries open longer
Disease control ENROLLING_BY_INVITATIONThis study looks at how well a special balloon coated with a drug (paclitaxel) works for people with narrowed or blocked arteries in the leg. About 200 adults with leg pain or wounds will be followed for 12 months to see if the balloon keeps the artery open and prevents the need …
Matched conditions: PTA (PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY)
Sponsor: Genoss Co., Ltd. • Aim: Disease control
Last updated May 26, 2026 11:38 UTC